NCT Number: NCT00444483
Structured Patient Education and Quality of Life of Elderly Patients With Diabetes Mellitus- a Prospective Study
The improvement of the quality of life (QoL) is one of the key treatment goals in patients with diabetes mellitus. Objective: Prospective study to evaluate the impact of structured diabetes education on the QoL in insulin-treated, elderly patients with type 2 diabetes mellitus. Inpatients with insulin treated type 2 diabetes or failure of oral antidiabetic therapy were successively recruited and participated in the structured inpatient diabetes treatment and teaching program (DTTP) for insulin therapy QoL was assessed before and six months after participation in the DTTP with the standardised questionnaire of Lohr analysing the subscales: social relations, physical complaints, worries about the future, diet restrictions, fear of hypoglycemia, and daily struggles.
Looking for future studies?
Notify MeKey information
Conditions
Age range
54 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
About this study
All patients with type 2 diabetes mellitus, who were older than 54 years and admitted by general practitioner to the inpatient unit of the university hospital of Jena, Germany, for participation in a structured DTTP for insulin therapy because of hyperglycemia, were candidates for successive inclusion in the study. All patients participated in a five day inpatient structured DTTP for single or split dose administration of intermediate-acting insulin which included instruction in insulin injection, self- monitoring, hypoglycemia, acute/late complications, nutrition and foot care. Quality of life was assessed by using a validated instrument, the standardised QoL- questionnaire of Lohr et al. (21) both before and six months after participation in the DTTP. This questionnaire consists of 58 Likert- scaled items comprising the subscales: social relations, physical complaints, worries about the future, diet restrictions, fear of hypoglycemia, and daily struggles. Higher scores reflect higher quality of life with 100% as an optimum quality of life. The primary outcome measure regarding patients metabolic control was the improvement of quality of life six months after DTTP.
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- diabetes mellitus, insulin therapy, age >54 years, hyperglycemia
Exclusion criteria
- dementia, severe neurological deficits, polioencephalitis, rejection of informed consent
Treatment and study plan
Primary outcomes
-
The primary outcome measure regarding patients metabolic control was the improvement of quality of life six months after DTTP.
Secondary outcomes
-
A secondary objective of the study was the comparison of QoL- subscale in patients already on insulin therapy with those newly on insulin therapy.
Sponsors and collaborators
Lead sponsor
Heidelberg University
Other
Collaborators
- University of Jena
Registry information
Official study title
Structured Treatment and Teaching of Elderly Patients With Type 2 Diabetes Mellitus
Important dates
- First posted
- Mar 7, 2007
- Registry last updated
- Mar 7, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Comparing Relative Strengths of Statistical Associations Between Psychological Traits and Vaccination-Related Outcomes I
NCT07172074
Behavior, Health Behavior
Iowa City, Iowa, United States
View Trial DetailsEnhancing Autonomic Regulation and Attention Through Biofeedback in Female Athletes
NCT07061834
Autonomic Regulation, Behavior
Ankara, Turkey (Türkiye)
View Trial DetailsStudy on the Use of the Insulin Pump Tandem X:2 With Control IQ Algorithm - Update
NCT05118945
Autoimmune Diseases, Diabetes Mellitus
Hanover, Lower Saxony, Germany
View Trial DetailsFully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB)
NCT05392452
Artificial Pancreas, Closed-Loop Glucose Control
Basel, Switzerland
View Trial Details